ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

XFOR Company Profile and Key Details

NASDAQ : XFOR

X4 Pharmaceuticals, Inc.

$0.21

0.0032+1.56%

At Close 4:00 PM

61.68

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

X4 Pharmaceuticals, Inc. (XFOR) stock surged +1.56%, trading at $0.21 on NASDAQ, up from the previous close of $0.20. The stock opened at $0.20, fluctuating between $0.20 and $0.22 in the recent session.

Stock Snapshot

0.2048

Prev. Close

0.2

Open

36.12M

Market Cap

173.66M

Number of Shares

0.2011

Day Low

0.2191

Day High

-1.09

P/E Ratio

66.23%

Free Float in %

-0.19

EPS (TTM)

0.26

Book Value

-0.46

Cash Flow per Share

1.36M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 15, 2025	0.20	0.22	0.20	0.21	1.36M
Apr 14, 2025	0.22	0.23	0.20	0.20	1.4M
Apr 11, 2025	0.21	0.22	0.20	0.21	1.91M
Apr 10, 2025	0.23	0.23	0.20	0.21	1.23M
Apr 09, 2025	0.21	0.23	0.20	0.23	2.79M
Apr 08, 2025	0.22	0.22	0.20	0.21	1.61M
Apr 07, 2025	0.20	0.23	0.19	0.21	2.29M
Apr 04, 2025	0.20	0.21	0.19	0.21	2.39M
Apr 03, 2025	0.23	0.23	0.20	0.21	1.58M
Apr 02, 2025	0.22	0.23	0.21	0.23	1.85M
Apr 01, 2025	0.23	0.25	0.22	0.22	1.85M
Mar 31, 2025	0.25	0.25	0.23	0.24	1.98M
Mar 28, 2025	0.26	0.28	0.25	0.25	1.52M
Mar 27, 2025	0.27	0.28	0.26	0.27	1.31M
Mar 26, 2025	0.26	0.27	0.25	0.27	2.05M
Mar 25, 2025	0.28	0.29	0.24	0.26	4.68M
Mar 24, 2025	0.31	0.31	0.29	0.30	1.17M
Mar 21, 2025	0.30	0.32	0.30	0.31	1.3M
Mar 20, 2025	0.30	0.32	0.30	0.30	998.06K
Mar 19, 2025	0.30	0.30	0.29	0.30	1.08M

Contact Details

Boston, MA 02134

United States

Website: https://www.x4pharma.comContact: 857 529 8300

About Company

X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase Ib clinical trial to treat chronic neutropenia and Waldenström macroglobulinemia. The company is also developing X4P-002, a CXCR4 antagonist for the treatment of brain cancers; and X4P-003, a CXCR4 antagonist for the treatment of CXCR4 disorders and primary immunodeficiencies. It has a license agreement with Abbisko Therapeutics Co., Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications. The company was founded in 2010 and is headquartered in Boston, Massachusetts.

Frequently Asked Questions

What is the current X4 Pharmaceuticals, Inc. (XFOR) stock price?

X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) stock price is $0.21 in the last trading session. During the trading session, XFOR stock reached the peak price of $0.22 while $0.20 was the lowest point it dropped to. The percentage change in XFOR stock occurred in the recent session was 1.56% while the dollar amount for the price change in XFOR stock was $0.00.

XFOR's industry and sector of operation?

The NASDAQ listed XFOR is part of Biotechnology industry that operates in the broader Healthcare sector. X4 Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of XFOR?

Dr. Robert David Arbeit
Senior Vice President of Clinical Devel. and Translational Research
Dr. Keith T. Flaherty M.D.
Founder & Member of Corporation Advisory Board
Mr. Mark Baldry M.B.A.
Chief Commercial Officer
Dr. Mary DiBiase Ph.D.
Chief Operating Officer
Dr. Richard Peters M.D., Ph.D.
Founder
Dr. Murray W. Stewart M.D.
Interim Chief Medical Officer & Director
Dr. Renato T. Skerlj Ph.D.
Founder
Dr. Arthur Taveras Ph.D.
Chief Scientific Officer
Mr. Adam S. Mostafa
Managing Director
Dr. Paula Ragan Ph.D.
Chief Executive Officer, Pres & Director

How XFOR did perform over past 52-week?

XFOR's closing price is 10.64% higher than its 52-week low of $0.19 where as its distance from 52-week high of $1.39 is -85.04%.

How many employees does XFOR have?

Number of XFOR employees currently stands at 143.

Link for XFOR official website?

Official Website of XFOR is: https://www.x4pharma.com

How do I contact XFOR?

XFOR could be contacted at phone 857 529 8300 and can also be accessed through its website. XFOR operates from 61 North Beacon Street, Boston, MA 02134, United States.

How many shares of XFOR are traded daily?

XFOR stock volume for the day was 1.36M shares. The average number of XFOR shares traded daily for last 3 months was 3.36M.

What is the market cap of XFOR currently?

The market value of XFOR currently stands at $36.12M with its latest stock price at $0.21 and 173.66M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

News

Investing Crypto Market Business US Stocks

Useful Links

Screener Market Data Insider Transactions Upgrades & Downgrades 52 Week Highs & Lows Unusual Volume Dividend Calendar Earnings Calendar

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Price Chart

Stock Price Today

Stock Snapshot

0.2048

Prev. Close

0.2

Open

36.12M

Market Cap

173.66M

Number of Shares

0.2011

Day Low

0.2191

Day High

-1.09

P/E Ratio

66.23%

Free Float in %

-0.19

EPS (TTM)

0.26

Book Value

-0.46

Cash Flow per Share

1.36M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 15, 2025	0.20	0.22	0.20	0.21	1.36M
Apr 14, 2025	0.22	0.23	0.20	0.20	1.4M
Apr 11, 2025	0.21	0.22	0.20	0.21	1.91M
Apr 10, 2025	0.23	0.23	0.20	0.21	1.23M
Apr 09, 2025	0.21	0.23	0.20	0.23	2.79M
Apr 08, 2025	0.22	0.22	0.20	0.21	1.61M
Apr 07, 2025	0.20	0.23	0.19	0.21	2.29M
Apr 04, 2025	0.20	0.21	0.19	0.21	2.39M
Apr 03, 2025	0.23	0.23	0.20	0.21	1.58M
Apr 02, 2025	0.22	0.23	0.21	0.23	1.85M
Apr 01, 2025	0.23	0.25	0.22	0.22	1.85M
Mar 31, 2025	0.25	0.25	0.23	0.24	1.98M
Mar 28, 2025	0.26	0.28	0.25	0.25	1.52M
Mar 27, 2025	0.27	0.28	0.26	0.27	1.31M
Mar 26, 2025	0.26	0.27	0.25	0.27	2.05M
Mar 25, 2025	0.28	0.29	0.24	0.26	4.68M
Mar 24, 2025	0.31	0.31	0.29	0.30	1.17M
Mar 21, 2025	0.30	0.32	0.30	0.31	1.3M
Mar 20, 2025	0.30	0.32	0.30	0.30	998.06K
Mar 19, 2025	0.30	0.30	0.29	0.30	1.08M

Contact Details

Boston, MA 02134

United States

Website: https://www.x4pharma.comContact: 857 529 8300

About Company

Frequently Asked Questions

What is the current X4 Pharmaceuticals, Inc. (XFOR) stock price?

XFOR's industry and sector of operation?

Who are the executives of XFOR?

How XFOR did perform over past 52-week?

XFOR's closing price is 10.64% higher than its 52-week low of $0.19 where as its distance from 52-week high of $1.39 is -85.04%.

How many employees does XFOR have?

Number of XFOR employees currently stands at 143.

Link for XFOR official website?

Official Website of XFOR is: https://www.x4pharma.com

How do I contact XFOR?

XFOR could be contacted at phone 857 529 8300 and can also be accessed through its website. XFOR operates from 61 North Beacon Street, Boston, MA 02134, United States.

How many shares of XFOR are traded daily?

XFOR stock volume for the day was 1.36M shares. The average number of XFOR shares traded daily for last 3 months was 3.36M.

What is the market cap of XFOR currently?

The market value of XFOR currently stands at $36.12M with its latest stock price at $0.21 and 173.66M of its shares outstanding.

Employees	143
Beta	0.58
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	143
Beta	0.58
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

XFOR Company Profile and Key Details

X4 Pharmaceuticals, Inc.

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions